pmid,title,journal,year,drug,disease
39411175,Drivers of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease: the threats of oxidative stress.,Frontiers in cardiovascular medicine,2024,Remdesivir,Non-alcoholic Fatty Liver Disease
32891697,Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?,Biochimie,2020,Remdesivir,Non-alcoholic Fatty Liver Disease
32564624,Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.,Annals of Saudi medicine,2020,Remdesivir,Non-alcoholic Fatty Liver Disease
32223926,Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.,Biochemical and biophysical research communications,2020,Remdesivir,Non-alcoholic Fatty Liver Disease
